Hospice & Palliative Care in Developing Countries



Similar documents
POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

Narcotic drugs used for pain treatment Version 4.3

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

How To Get A Tirf

Abstral Prescriber and Pharmacist Guide

OPIOIDS CONVERSION GUIDELINES 2007

Got Pain? 11/19/2013. Pain Kill Beyond The Pill. Yet it is often inadequately treated.

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist

WITHDRAWAL OF ANALGESIA AND SEDATION

Medications for chronic pain

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

Blueprint for Prescriber Continuing Education Program

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians

UNIT VIII NARCOTIC ANALGESIA

Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013

Considerations when Using Controlled Substances to Treat Chronic Pain

Lora McGuire MS, RN Educator and Consultant Barriers to effective pain relief

Autism Spectrum Disorder Formulation & Resource Guide

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Pain Management in Palliative and Hospice Care

Pharmacy Technician Training Program. Minimum Competencies

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY

Passionate concerns about welfare and ethics have created an environment where discussions about

Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Community Pharmacy. What is Compounding?

HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida

Crisis Management in Hospice Patients

Community Pharmacists in NHS Rotherham

Ultram (tramadol), Ultram ER (tramadol extended-release tablets); Conzip (tramadol extended-release capsules), Ultracet (tramadol / acetaminophen)

A Guide to pain relief medicines For patients receiving Palliative Care

Working together for healthier living

Naloxone treatment of opioid overdose

1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

MEDICATION ABUSE IN OLDER ADULTS

Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin

Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

Pain Medication Taper Regimen Time frame to taper off days

Nurses Self Paced Learning Module on Pain Management

IACUC Guideline LARGE ANIMAL FORMULARY

MUSC Opioid Analgesic Comparison Chart

Nursing 113. Pharmacology Principles

Opioid Conversion Ratios - Guide to Practice 2013

How To Treat Anorexic Addiction With Medication Assisted Treatment

Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management

BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET

Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer

ABC of palliative care: Principles of palliative care and pain control

Drug Testing to Support Pain Management

A Healthesystems Clinical Analysis. Insidious Incrementalism of Opioid Use in Workers Compensation

Welcome to the Internal Medicine Intern Teaching Conference Series

Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD): principles for classifying and quantifying drug use

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

PPP 1. Continuation of a medication to ensure continuity of care

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia

1. What are anti-epileptic drugs? Anti-epileptic drugs (AEDs) are prescribed to control seizures. They do not cure epilepsy.

Update on Buprenorphine: Induction and Ongoing Care

How To Take A Strong Opioid Painkiller

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

Anticipating And Preparing For Predictable Clinical Challenges In The Medical Care Of The Terminally Ill Person Wishing To Die At Home.

IACUC Guideline RODENT ANESTHESIA & ANALGESIA FORMULARY

Reducing Narcotics Misuse and Abuse in Workers Compensation

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

Emergency and inpatient treatment of migraine: An American Headache Society

Basic Medication Administration Exam RN (BMAE-RN) Study Guide

Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014

END OF LIFE MEDICINES INFORMATION PACK

VISTARIL (hydroxyzine pamoate) Capsules and Oral Suspension

OPIOID NEUROTOXICITY - BACK TO BASICS. Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow

MEDICATION GUIDE. What is Morphine Sulfate Oral Solution?

Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide

One example: Chapman and Huygens, 1988, British Journal of Addiction

This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics

Pain management. The WHO analgesic ladder

DELEGATION OF MEDICATION ADMINISTRATION TO UAP Position Statement for RN and LPN Practice

OPIOID PAIN MEDICATION Agreement and Informed Consent

Review of Pharmacological Pain Management

Southlake Psychiatry. Suboxone Contract

Transcription:

Hospice & Palliative Care in Developing Countries Compounding End of Life Medications WHO Recommendations to Developing Countries Russ Zakarian, Pharm.D. FASCP

What is Compounding? Compounding is the method of preparing customized medications to help meet unique physician and patient needs.

Pharmacy The art or profession of preparing and preserving drugs, and of compounding and dispensing medication according to the prescriptions of physicians. Early 20 th Century Webster Dictionary

Also known as a problem solver, a compounding pharmacist s ultimate goal in preparing customized medications is to help the physician and patient achieve a more positive therapeutic outcome.

Hospice Alternative routes of administration Individualized pain management Nausea & vomiting Inhalation therapy Emergency kits Mouth ulcers Saliva stimulants Adjunctive therapies

Meeting Unique Needs In: Hospice Pain Management Bio-identical Hormone Replacement Therapy Veterinary applications Household pets Equine Zoos Exotics Dental Dermatology

Compounded Dosage Forms Oral capsules and liquids Transdermals Lollipops and popsicles Troches, tablet triturates and sublingual drops Rapid dissolve tablets Suppositories, enemas and rectal rockets

Compounded Dosage Forms Nasal and otic preparations Topical creams, ointments, gels, powders and sprays Oral adhesives, mouthwashes and rinses Sterile products Inhalation solutions, injections, ophthalmics, TPNs

Compounded Capsules Medications formulated in capsules enable the patient to get the exact dosage needed, while avoiding unwanted dyes and fillers.

Compounding for Pain Management Capsules Morphine Sulfate SR caps up to 900mg/cap Oxycodone SR caps

Compounded Oral Liquids Preparing medications in a liquid form allowa the patient who can t swallow pills to get the appropriate medicine in a vast range of flavors, such as tutti-frutti or vanilla butternut.

Compounded Oral Liquids Difficulty swallowing Avoid unwanted ingredients Increased compliance Anhydrous formulations

Compounding for Pain Management Oral Liquids Magic Mouthwash Morphine oral solutions 50mg/ml (commercial dose is 20mg/ml)

Transdermal Gels

Transdermal Drug Delivery Drug Classes Used in Transdermals NSAIDS Muscle relaxants Antinausea agents Antiviral agents Anti-inflammatory agents Anesthetics Anti-anxiety agents

Transdermal Drug Delivery Drug Classes Used in Transdermals Anti-diabetic agents Antidepressant / anti-psychotic agents Anti-hypertensive agents Thyroid medication Antihistamines Anti-infective agents

Compounding for Pain Management Transdermal Gels ABHR Alprazolam Dexamethazone Diazepam Gabapentin Haloperidol Ketamine

Compounding for Pain Management, cont Transdermal Gels Hydroxyzine Metochlopramide Oxycodone Promethazine Temazepam Diphenhydramine

Medicated Lollipops Local effects Anesthetic Antifungal Antiviral Anti-inflammatory Saliva stimulant Healing agents

Medicated Lollipops Systemic effects Anti-anxiety Antipyretic Analgesic Narcotic Non-narcotic

Troches Soft gelatin-flavored troches, such as those prepared in the 24 and 30-count molds, provide medication in an easy-to-take and pleasant-tasting form.

Rapid Dissolve Tablets

Compounded Sterile Products USP <797> standard compliant Infusion pain management with CADD infusion pumps Routes of infusion: SQ, MediPort, PICC MS 50mg/cc Hydromorphone 10mg/cc Fentanyl 50mcg/cc Lorazepam 2mg/cc Midazolam 5mg/cc

Suppositories and Enemas Rectal or vaginal use Helpful to patients who have difficulty in swallowing, nausea/vomiting Injections cause pain, anxiety Rapid local affect

Compounding for Pain Management Suppositories ABHR Chloral Hydrate Diazepam Morphine Phenytoin Gabapentin

The Rectal Rocket

Quality & Safety Steps in the Compounding Laboratory

IAHPC Meds for Palliative Care Pharmacist Prospective List includes 33 medications of which 17 already included in WHO list. Medications were rated on effectiveness and safety profile. Final list was approved by panel of 28 professional organizations. Refer to handout for list of meds.

Anti-depressants TCA local anesthetic type properties due to its sodium channel blockade. Not shared by SSRI anti-depressants. Decreasing depression can de-amplify the sensation of pain. Plasma steady state takes 2 weeks.

Adverse Drug Effects Amitriptyline (TCA) Dose related Anti-cholinergic effects Co-morbidities such as CV disease and drug interactions limits its use. Desipiramine (TCA) Lowest risk of anti-cholinergic effects Mirtazapine/Trazadone Dual action of NaSSA and Tetracyclic Cymbalta (not on the IAHPC list) FDA approved for nerve injury pain

OPIOID ANALGESICS Opioids classifies as full morphine-like agonists. Do not exhibit dose-ceiling expect when limited by toxicities. Antagonize NMDA receptors mu, kappa, delta receptors are target molecules for analgesia

MORPHINE Gold standard IAHPC list both IR and SR forms WHO only list IR forms Highest dose list for SR is 30mg tabs MSIR sol dose listed is 10mg/5ml

SPECIAL CONSIDERATIONS Neurotoxicity Opioid Induced Hyperalgesia (OIH) more pain with more drug Tolerance Neuronal excitotoxicity via cell death Changes in glutamate availability NMDA receptor excitability Ratio of M6G/M3G NMDA blockers ketamine, clonidine, methadone Signal of disease progression

OXYCODONE mu & kappa receptor agonist Metabolized CYP 2D6 pathway Dose adjustments necessary with drugs that inhibit CYP 2D6 (Haldol,Paxil,Prozac) 10-20% metabolized to oxymorphone. Oxycodone IR 5mg on IAHPC list Oxycodone SR not included

FENTANYL Potent mu agonist PO conversion to patch Convert oral opioid to equivalent dose of oral morphine Half this dose and convert to mcg for appropriate patch size Reverse should not be used Metabolized CYP 450 3A4 25mcg for Opioid Naïve patients

METHADONE Elimination half-life (8-59 hours) is longer than its duration of action (4-5 hours) High dose and prolonged QT intervals a marker for deadly cardiac problems Dose conversion is challenging Not a first line drug DEA restricts distribution to 10mg tabs

LIST OF ESSENTIAL MEDICATIONS, CONT Bisacodyl/Senna/Mineral Oil Prednisone/Dexamethasone Acetaminophen Valium/Lorazepam Midazolam/Zolpidem Haldoperidol Gabapentin

List of Essential Medications,cont IBU Carbamazepine Codiene Loperamide Metoclopramide Tramadal

GETTING PAST THE STIGMA Reasons Pharmacist stock inadequate supplies of opiods Concerns with DEA monitor usage Illicit use and fraud Fear of theft

Questions??? For more information Russ Zakarian,Pharm.D. Model Drug Pharmacy 1-800-585-3785 russ@modeldrug.com